Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bertagna F et al. – These results indicate that F–18 FDG–PET/CT is a useful diagnostic tool in patients with differentiated thyroid carcinoma and with negative I–131 total body scans and high Tg levels. The levothyroxine therapy regimen does not influence F–18 FDG–PET/CT results and the rate of F–18 FDG–PET/CT positive results appears to correlate with the Tg levels. The highest accuracy is reached when the study is performed for patients with Tg levels higher than 21 ng/mL.


Today in Endocrine Oncology...keeping you current

The role of let-7 in cell differentiation and cancer
Endocrine-Related Cancer, 02/09/10

Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment
Endocrine-Related Cancer, 02/09/10

MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype
Endocrine-Related Cancer, 02/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address